Dr Julie E Voss, MD | |
13317 Ne 175th St Ste N, Woodinville, WA 98072-3517 | |
(425) 434-1500 | |
(425) 977-9485 |
Full Name | Dr Julie E Voss |
---|---|
Gender | Female |
Speciality | Dermatology |
Experience | 32 Years |
Location | 13317 Ne 175th St Ste N, Woodinville, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356309678 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | MD00033431 (Washington) | Secondary |
207NS0135X | Dermatology - Procedural Dermatology | MD00033431 (Washington) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Julie Voss Md Ps | 4981026507 | 3 |
News Archive
Non-small cell lung cancer patients survive longer when their treatment includes durvalumab following platinum-based chemoradiotherapy, according to research led by Moffitt Cancer Center.
Medical research charity Arthritis Research UK has awarded researchers at University College London and the University of Nottingham a grant of £800,000 to develop new treatments for severe arthritis pain.
Blood expression levels of genes targeted by the stress hormones called glucocorticoids could be a physical measure, or biomarker, of risk for developing Post-Traumatic Stress Disorder (PTSD), according to a study conducted in rats by researchers at the Icahn School of Medicine at Mount Sinai and published August 11 in Proceedings of the National Academy of Sciences (PNAS).
The main applications for cannabis testing is to ensure that the product produced, whether the flower itself, tinctures, edibles, etc. contain acceptable levels of approved pesticide or other residues leftover from the growing or processing process.
› Verified 9 days ago
Entity Name | Julie Voss Md Ps |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215577028 PECOS PAC ID: 4981026507 Enrollment ID: O20200626000773 |
News Archive
Non-small cell lung cancer patients survive longer when their treatment includes durvalumab following platinum-based chemoradiotherapy, according to research led by Moffitt Cancer Center.
Medical research charity Arthritis Research UK has awarded researchers at University College London and the University of Nottingham a grant of £800,000 to develop new treatments for severe arthritis pain.
Blood expression levels of genes targeted by the stress hormones called glucocorticoids could be a physical measure, or biomarker, of risk for developing Post-Traumatic Stress Disorder (PTSD), according to a study conducted in rats by researchers at the Icahn School of Medicine at Mount Sinai and published August 11 in Proceedings of the National Academy of Sciences (PNAS).
The main applications for cannabis testing is to ensure that the product produced, whether the flower itself, tinctures, edibles, etc. contain acceptable levels of approved pesticide or other residues leftover from the growing or processing process.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Julie E Voss, MD 11410 Ne 124th St, Kirkland, WA 98034-4305 Ph: (435) 434-1500 | Dr Julie E Voss, MD 13317 Ne 175th St Ste N, Woodinville, WA 98072-3517 Ph: (425) 434-1500 |
News Archive
Non-small cell lung cancer patients survive longer when their treatment includes durvalumab following platinum-based chemoradiotherapy, according to research led by Moffitt Cancer Center.
Medical research charity Arthritis Research UK has awarded researchers at University College London and the University of Nottingham a grant of £800,000 to develop new treatments for severe arthritis pain.
Blood expression levels of genes targeted by the stress hormones called glucocorticoids could be a physical measure, or biomarker, of risk for developing Post-Traumatic Stress Disorder (PTSD), according to a study conducted in rats by researchers at the Icahn School of Medicine at Mount Sinai and published August 11 in Proceedings of the National Academy of Sciences (PNAS).
The main applications for cannabis testing is to ensure that the product produced, whether the flower itself, tinctures, edibles, etc. contain acceptable levels of approved pesticide or other residues leftover from the growing or processing process.
› Verified 9 days ago